Prescribing of Hormone Therapy in Menopause and Postmenopause

References

• McKinlay J. From ‘promising report’ to ‘standard procedure’: seven stages in the career of medical innovation. Milbank Mem Quart 1981; 59: 374–411
   Google Scholar
• Hemminki E, Sihvo S. A review of postmenopausal hormone therapy recommendations: potential for selection bias. Obstet Gynecol 1993; 82: 1021–8
   PubMed Web of Science ®Google Scholar
• Hemminki E, Kennedy D L, Baum C, McKinlay S M. Prescribing of noncontraceptive estrogens and progestins in the United States 1974–1986. Am J Public Health 1988; 78: 1479–81
   PubMed Web of Science ®Google Scholar
• Hemminki E. Use of combined estrogen—progestin replacement therapy — an example of the dissemination of new indications for an old technology. Int J Technol Assess Health Care 1988; 4: 511–19
   PubMedGoogle Scholar
• Hemminki E, Topo P, Malin M, Kangas I. Physicians' view on hormone therapy around and after menopause. Maturitas 1993; 16: 163–73
   PubMed Web of Science ®Google Scholar
• Topo P, Klaukka T, Hemminki E, Uutela A. Use of hormone replacement therapy in 1976–1989 by 45 to 64-year-old Finnish women. J Epidemiol Community Health 1991; 45: 277–80
   PubMed Web of Science ®Google Scholar
• Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993; 46: 211–19
   PubMed Web of Science ®Google Scholar
• Topo P, Køster A, Holte A, Collins A, Landgrcn B-M, Hemminki E, Uutela A. Trends in the use of climacteric and postclimacteric hormones in Nordic countries. Maturitas 1995; 22: 89–95
   PubMed Web of Science ®Google Scholar
• Finnish Statistics on Medicines 1995. National Agency for Medicines and Social Insurance Institution, Helsinki 1996
   Google Scholar
• Toiviainen H. Lääkäreiden vaihdevuosihoitokäytännöt. Aiheita 9/1977. Stakes, Helsinki 1997
   Google Scholar
• Helakorpi S, Berg M-A, Uutela A, Puska P. Health behaviour among Finnish adult population. National Public Health Institute, Helsinki 1995, Spring 1995. Publications of the National Public Health Institute. B 14/1995
   Google Scholar
• Helakorpi S, Uutela A, Prättälär P. Puska health behaviour among Finnish adult population, Spring 1996. National Public Health Institute, Helsinki 1996, Publications of the National Public Health Institute. B 12/1996
   Google Scholar
• Topo P. Dissemination of climacteric and postmenopausal hormone therapy in Finland, an example of the social shaping of a medical technology. Stakes, Helsinki 1997, Research reports 78
   Google Scholar
• Topo P. Climacteric hormone therapy in medical and lay texts in Finland from 1955 to 1992. Soc Sci Med, in press
   Web of Science ®Google Scholar
• Topo P, Hemminki E, Uutela A. Women's choice and physicians' advice of menopausal and postmenopausal hormone therapy. Int J Health Sci 1993; 4: 101–9
   Google Scholar
• Hemminki E, Topo P, Kangas I, Uutela A. Vaihdevuodet ja terveydenhuolto. Sosiaalilaaketiet Aikak 1991; 28: 71–81
   Google Scholar
• Mattila-Lindy S, Hemminki E, Malin-Silverio M, Makkonen K, Topo P, Mäntyranta T, Kangas I. Physicians gender and clinical opinions of reproductive health matters. Women Health, in press
   Web of Science ®Google Scholar
• Kennedy D L, Baum C, Forbes M B. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol 1985; 65: 441–6
   PubMed Web of Science ®Google Scholar
• Wysowski D K, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982–1992. Obstet Gynecol 1995; 85: 6–10
   PubMed Web of Science ®Google Scholar
• Jolleys J V, Olesen F. A comparative study of prescribing hormone replacement therapy in USA and Europe. Maturitas 1996; 23: 47–53
   PubMed Web of Science ®Google Scholar
• Stadel B V, Weiss N. Characteristics of menopausal women: a survey of King and Pierce counties in Washington, 1973–1974. Am J Epidemiol 1975; 102: 209–16
   PubMed Web of Science ®Google Scholar
• Pfeffer R I. Estrogen use in postmenopausal women. Am J Epidemiol 1977; 105: 21–9
   PubMed Web of Science ®Google Scholar
• Hemminki E, Brambilla D J, McKinlay S M, Posner J G. Use of estrogens among middle-aged Massachusetts women. DICP Ann Pharmacother 1991; 25: 418–23
   PubMedGoogle Scholar
• Egeland G M, Matthews K A, Kuller L H, Kelsey S F. Characteristics of noncontraceptive hormone users. Prev Med 1988; 17: 403–11
   PubMed Web of Science ®Google Scholar
• Harris R B, Laws A, Reddy V M, King A, Haskell W L. Are women using postmenopausal estrogens? A community survey. Am J Public Health 1990; 80: 1266–8
   PubMed Web of Science ®Google Scholar
• Cauley J A, Cummings S R, Black D M, Mascioli S R, Seeley D G. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990; 163: 1438–44
   PubMed Web of Science ®Google Scholar
• Derby C A, Lamont Hume A, McFarland Barbour M, McPhillips J B, Lasater T M, Carleton R A. Correlates of postmenopausal estrogen use and trends through the 1980s in two Southeastern New England communities. Am J Epidemiol 1993; 137: 1125–35
   PubMed Web of Science ®Google Scholar
• Folsom A R, Mink P J, Sellers T A, Hong C P, Zheng W, Potter J D. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 1995; 85: 1128–32
   PubMed Web of Science ®Google Scholar
• Kaufert P L. The menopausal transition; the use of estrogen. Can J Public Health 1986; 77: 86–91
   PubMed Web of Science ®Google Scholar
• MacLennan A H, MacLennan A, Wilson D. The prevalence of oestrogen replacement therapy in South Australia. Maturitas 1993; 16: 175–83
   PubMed Web of Science ®Google Scholar
• Shelley J M, Smith A MA, Dudley E, Dennerstein L. Use of hormone replacement therapy by Melbourne women. Aust J Public Health 1995; 19: 387–92
   PubMedGoogle Scholar
• O'Connor V M, Del Mar C B, Sheehan M, Siskind V, Fox-Young S, Cragg C. Do psycho-social factors contribute more to symptom reporting by middle-aged women than hormonal status?. Maturitas 1995; 20: 63–9
   Web of Science ®Google Scholar
• Spector T D. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. Br Med J 1989; 299: 63–9
   Google Scholar
• Sinclair H K, Bond C M, Taylor R J. Hormone replacement therapy: a study of women's knowledge and attitudes. Br J Gen Pract 1993; 43: 365–70
   PubMed Web of Science ®Google Scholar
• Garton M, Reid D, Rennie E. The climacteric, osteoporosis and hormone replacement; views of women aged 45–49. Maturitas 1995; 21: 7–15
   PubMed Web of Science ®Google Scholar
• Lancaster T, Surman G, Lawrence M, Mant D, Vessey M, Thorogood M, Yudkin P, Daly E. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Commun Health 1995; 49: 389–94
   PubMed Web of Science ®Google Scholar
• Griffiths F, Convery B. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy. Br J Gen Pract 1995; 45: 355–8
   PubMed Web of Science ®Google Scholar
• Banks E, Crossley B, English R, Richardson A. High prevalence of use is not confined to doctors. Br Med J 1996; 312: 638
   PubMedGoogle Scholar
• Groeneveld F PMJ, Bareman F P, Barentsen R, Dokter H J, Drogendijk A C, Hoes A W. Determinants of first prescription of hormone replacement therapy A follow-up study among 1689 women aged 45–60 years. Maturitas 1995; 20: 81–9
   Web of Science ®Google Scholar
• Barentsen R, Foekema H A, Bezemer W, van Stiphout F LM. The view of women aged 45–65 and their partners on aspects of the climacteric phase of life. Eur J Obstet Gynecol Reprod Biol 1994; 57: 96–101
   Web of Science ®Google Scholar
• Ringa V, Ledésert B, Gueguen R, Schiele F, Breart G. Determinants of hormonal replacement therapy in recently postmenopausal women. Eur J Obstet Gynecol Reprod Biol 1992; 45: 193–200
   PubMed Web of Science ®Google Scholar
• Pedersen S H, Jeune B. Prevalence of hormone replacement therapy in a sample of middle-aged women. Maturitas 1988; 9: 339–45
   PubMed Web of Science ®Google Scholar
• Køster A. Hormone replacement therapy: use patterns in 51-year-old Danish women. Maturitas 1990; 12: 345–56
   PubMed Web of Science ®Google Scholar
• Holte A. Prevalence of climacteric complaints in a representative sample of middle-aged women in Oslo, Norway. J Psychosom Ostet Gynaecol 1991; 12: 303–317
   Web of Science ®Google Scholar
• Bengtsson C, Lindquist O, Redvall L. Menstrual status and menopausal age of middle-aged Swedish women. Acta Obstet Gynecol Scand 1981; 60: 269–75
   PubMed Web of Science ®Google Scholar
• Persson I, Adami H-O, Lindberg B S, Johansson E DB, Manell P. Practice and patterns of estrogen treatment in climacteric women in a Swedish population A descriptive epidemiological study. Part I. Acta Obstet Gynecol Scand 1983; 62: 289–96
   PubMed Web of Science ®Google Scholar
• Hammar M, Berg G, Fåhraeus L, Larsson-Cohn U. Climacteric symptoms in an unselected sample of Swedish women. Maturitas 1987; 6: 345–50
   Google Scholar
• Andersson K, Mattsson L-Å, Milsom I. Use of hormone replacement therapy. Lancet 1996; 348: 1521
   PubMed Web of Science ®Google Scholar
• Oddens B J, Boulet M J, Lehert P, Visser A P. Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries. Maturitas 1992; 15: 171–81
   PubMed Web of Science ®Google Scholar
• Dawnson D A, Thompson G B. Breast cancer risk factors and screening: United States 1987. Vital and Health Statistics. Series 10, U.S. Department of Health and Human Services, Hyattsville 1990, No. 172
   Google Scholar
• Kritz-Silverstein D, Barrett-Connor E. Long-term postmenopausal hormone use, obesity, and fat distribution in older women. J Am Med Assoc 1996; 275: 46–9
   PubMed Web of Science ®Google Scholar
• Barlow D H, Grossett K A, Hart D M. A study of the experience of Glasgow women in the climacteric years. Br J Obstet Gynaecol 1989; 96: 1192–7
   PubMedGoogle Scholar
• Johannes C B, Crawford S L, Posner J G, McKinlay S M. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994; 140: 439–452
   PubMed Web of Science ®Google Scholar
• Pasley B H, Standfast S J, Katz S H. Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981. Public Health Rep 1984; 99: 424–9
   PubMed Web of Science ®Google Scholar
• Schwartz M, Anwah I, Levy R N. Variations in treatment of postmenopausal osteoporosis. Clin Ortop 1985; 192: 180–4
   Google Scholar
• Greendale G A, Carlson K J, Schiff I. Estrogen and progestin therapy to prevent osteoporosis: Attitudes and practices of general internists and gynecologists. J Gen Intern Med 1990; 5: 464–9
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. Postmenopausal estrogens —current prescribing patterns of San Diego Gynecologists. West J Med 1986; 144: 620–1
   PubMedGoogle Scholar
• Ross R K, Paganini-Hill A, Roy S, Chao A, Henderson B E. Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles Gynecologists: Possible Implications for Public Health. Am J Public Health 1988; 78: 516–19
   PubMed Web of Science ®Google Scholar
• Underwood P N, Boyle I T. A survey of treatment attitudes to postmenopausal osteoporosis. Scott Med J 1983; 28: 259–64
   PubMed Web of Science ®Google Scholar
• Shears M-R. Brighton practitioners' attitudes to HRT. Practitioner 1989; 233: 146–9
   PubMedGoogle Scholar
• Bryce F C, Lilford R J. General practitioners, use of hormone-replacement therapy in Yorkshire. Eur J Obstet Gynecol Reprod Biol 1990; 37: 55–61
   PubMed Web of Science ®Google Scholar
• Wilkes H C, Meade T W. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice framework. Br Med J 1991; 302: 1317–20
   PubMed Web of Science ®Google Scholar
• Backe B, Hunskaar S, Skolbekken J A. Menopause: A national survey in Norway. Scand J Prim Health Care 1992; 10: 179–84
   PubMedGoogle Scholar
• Isaacs A J, Britton A R, McPherson K. Utilisation of hormone replacement therapy by women doctors. Br Med J 1995; 311: 1399–401
   PubMed Web of Science ®Google Scholar
• Utian W H. Direction, misdirection and misconception in menopause research and management. Br J Obstet Gynaecol 1996; 103: 736–9
   PubMedGoogle Scholar
• Holte A. Influences of natural menopause on health complaints: a prospective study on healthy Norwegian women. Maturitas 1992; 14: 127–41
   PubMed Web of Science ®Google Scholar
• Hemminki E, Topo P, Kangas I. Experience and opinions of climacterium by Finnish women. Eur J Obstet Gynecol Reprod Biol 1995; 62: 81–7
   PubMed Web of Science ®Google Scholar
• Hemminki E. The future of population strategies in prevention: drugs for all?. Scand J Soc Med 1995; 23: 225–6
   PubMedGoogle Scholar
• McCrea F B, Markle G E. The estrogen replacement controversy in the USA and UK: different answers to the same question?. Soc Studies 1984; 14: 1–26
   Google Scholar
• 1995, Suomen tilastollinen vuosikirja 1948, 1971, 1995. Tilastokeskus, Helsinki 1949, 1971
   Google Scholar
• Kolari R. Kuolleisuus, Kohorttikuolleisuus Suomesta v:sta 1851 lähtien. 1980; 70, Tilastokeskus, Tutkimuksia No. 57, Helsinki
   Google Scholar
• Rose G. The strategy of preventive medicine. Oxford University Press, Oxford 1992
   Google Scholar